Binance Fights Back: CZ's Beanie Baby Defense Against SEC's Amended Complaint
The motion, submitted on November 4, challenges the SEC's assertions regarding several tokens, including Axie Infinity Shards (AXS) and Filecoin (FIL). Zhao contends that the SEC's approach is arbitrary and lacks a consistent legal standard, likening its handling of crypto to that of“Beanie Babies.”
SEC's Legal Claims Under ScrutinyIn its amended complaint, the SEC alleges that certain token transactions constitute securities, extending beyond the initial offerings to secondary market resales. Binance & Zhao's defense maintains that these resales should not be classified as securities transactions, emphasizing that each crypto transaction must meet specific criteria under securities law.
Filing excerpt via United States District Court
The motion asserts that the SEC's claims“fail as a matter of law” and seeks a dismissal with prejudice, suggesting the SEC's theories are flawed rather than the facts at hand.
The Ongoing Regulatory BattleThe SEC's case against Binance represents a significant challenge in the evolving landscape of cryptocurrency regulation. As the legal battle unfolds, scrutiny of influencer and celebrity involvement in crypto projects is increasing, raising concerns about market integrity and investor protections. Binance's fight against the SEC is emblematic of broader tensions within the crypto industry, where clarity and regulation remain contentious issues, further complicated by ongoing legal battles faced by other crypto exchanges and projects.
This ongoing conflict will likely influence how regulators approach cryptocurrency, affecting market sentiment and the future of digital assets in the United States.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment